2009 Publications

  1. Ahimastos A, Aggarwal A, Savarirayan R, Kingwell B, Dart AM. A role of plasma transforming growth factor-beta and matrix metalloproteinase in aortic aneurysm surveillance in Marfan syndrome? Atherosclerosis 2009: published on line 8 Aug 09.
  2. Baumert M, Lambert GW, Dawood T, Lambert EA, Esler MD, McGrane M, Barton D, Sanders P, Nalivaiko E. Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder. Am J Physiol Heart Circ Physiol 2009;297(2):H674-9.
  3. Bertovic DA, Dart AM. Importance of aortic dimensions in determining pulse pressure in elderly hypertensives. Asia Pacific Cardiology 2009;2(1):35-37.
  4. Brown AD, Barton DA, Lambert GW. Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs 2009;23(7):583-602.
  5. Butler MJ, Eccleston D, Clark DJ, Ajani AE, Adnrianopoulos N, Brennan A, New G, Black A, Szeto G, Ried CM, Yan BP, Shaw JA, Dart AM, Duffy SJ. The effects of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stent. Am Heart J. 2009;157:899-907. Citations =; IF = 3.6.
  6. Camuglia A, Hengel C, Taylor AJ, Manins V. Case Report and Review: Epicardial Coronary Artery Fibromuscular Dysplasia. Heart, Lung and Circulation 2009;18(2):151-4.
  7. Carey AL, Kingwell BA. Novel pharmacological approaches to combat the obesity and insulin resistance: Targeting skeletal muscle with exercise mimetics. Diabetologia 52(10):2015-26, 2009.
  8. Drew BG, Duffy SJ, Formosa MF, Natoli AK, Henstridge DC, Penfold SA, Thomas WG, Mukhamedova N, de Courten B, Forbes JM, Yap FY, Kaye DM, van Hall G, Febbraio MA, Kemp BE, Sviridov D, Steinberg GR, Kingwell BA. HDL modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation 2009;119(15):2103-11,.
  9. Du XJ, Bathgate RAD, Samuel CS, Dart AM, Summers RJ. Cardiovascular effects of relaxin: from basic science to clinical therapy (invited review). Nat Rev Cardiol 2010;7(1):48-58
  10. Du X-J, Xu Q, Lekgabe E, Gao X-M, Kiriazis H, Moore X-L, Dart AM, Tregear GW, Bathgate RAD, Samuel CS: Reversal of Cardiac Fibrosis and Related Dysfunction by Relaxin. (Invited review). Ann NY Acad Sci 2009;1160:278-284.
  11. Eisenhardt SU, Habersberger J, Murphy A, Chen YC, Woollard KJ, Bassler N, Qian H, von Zur Muhlen C, Hagemeyer CE, Ahrens I, Chin-Dusting J, Bobik A, Peter K. Dissociation of pentaric to monomeric C-reactive protein on activated platelets localises inflammation to atherosclerotic plaques. Circ Res. 2009;105(2):128-37.
  12. Esler M. Depressive illness, the sympathetic nervous system and cardiac risk. J Hypertens 2009;27(12):2349-50.
  13. Esler MD. Heart and mind: psychogenic cardiovascular disease. J Hypertens 2009;27(4):692-5.
  14. Freeman, M., Clark, D., Andrianopoulos, N., Duffy, S.J., Lim, H.S., Brennan, A., Charter, K., Shaw, J., Horrigan, M., Sebastian, M., Ajani, A.E., Reid, C., Omar Farouque, H.M. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents. Catheterization and Cardiovasc Interventions, 2009; 73: 763-8.
  15. Freilich M, Stub D, Esmore D, Negri J, Salamonsen R, Bergin P, Leet A, Richardson M, Taylor AJ, Woodard J, Kaye D, Rosenfeldt F. Recovery from Anthracycline Cardiomyopathy after long-term support with a continuous flow left ventricular assist device. J Heart Lung Transplant. 2009 Jan;28(1):101-3.
  16. Gao XM, Ming Z, Su Y, Fang L, Kiriazis H, Qi X, Dart AM, Du XJ. Infarcted size and post-infarct inflammation determine the risk of cardiac rupture in mice. Intern J Cardiol (Accepted 10 January 2009, In press).
  17. Henstridge DC, Drew BG, Formosa MF, Natoli AK, Cameron-Smith D, Duffy SJ, Kingwell BA. The effect of the nitric oxide donor sodium nitroprusside on glucose uptake in human primary skeletal muscle cells. Nitric Oxide (in press), 2009.
  18. Henstridge DC, Duffy SJ, Formosa MF, Ahimastos AA, Thompson BR, Kingwell BA. Oral nitrate therapy does not affect glucose metabolism in healthy humans. Clin Exp Pharmacol and Physiol, 36(11):1086-92, 2009.
  19. Jelinek M, Vale MJ, Liew D, Griggs L, Dart AM, Hare DL, Best JD. The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications - two years follow-up. HL& Cir 2009 (In press) Accepted 6 July09.
  20. Kaye DM, Byrne MJ, Power JM. LETTER TO THE EDITOR. Reply to Bridges. Gene Therapy 2009
  21. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009;373(9671):1275-81.
  22. La Gerche A, Taylor AJ and Prior D. Athlete's heart: the potential for multi-modality imaging to address the critical remaining questions. JACC; Cardiovascular imaging 2009;2(3):350-63.
  23. Leet AS, Bergin PJ, Richardson M, Taylor AJ, Esmore D, Kaye DM. Outcomes Following De Novo CNI-Free Immunosuppression After Heart Transplantation: A Single-Centre Experience. American Journal of Transplantation 2009;9(1):140-8.
  24. Lefkovits L and Taylor AJ. Screening for coronary artery disease in type 2 diabetic patients. Diabetes Management Journal 2009:27;6-7.
  25. Lim, H.S., Farouque, O., Andrianopoulos, N., Yan, B.P., Lim, C.C.S., Brennan, A.L., Reid, C.M., Freeman, M., Charter, K., Black, A., New, G., Ajani, A.E., Duffy, S.J., Clark, D.J. on behalf of the Melbourne Interventional Group. Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock. Am Coll Cardiol: Cardiovas Intervention, 2009; 2: 146-52
  26. Maeder M, Leet A, Ross A, Esmore D, Kaye DM. Changes in right ventricular function during continuous flow left ventricular assist device support. J Heart Lung Transplantation.2009 Apr;28(4):360-6.
  27. Maeder MT, Kaye DM. Heart Failure with Normal Ejection Fraction. J Am Coll Cardiol 2009;53:905-18.
  28. Manins V, Habersberger J, Pfluger H, Taylor AJ. Cardiac magnetic resonance imaging in the evaluation of cardiac sarcoidosis – an Australian single centre experience. Internal Medicine Journal 2009;39(2):77-82.
  29. Mensink RP, Nestel P. Trans fatty acids and cardiovascular risk markers: does the source matter? Curr Opin Lipidol 2009;20:1-2.
  30. Mitchell DA, Lambert G, Secher NH, Raven PB, van Lieshout J, Esler MD. Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans. J Physiol 2009;587(Pt 11):2589-97.
  31. Mukhamedova N, Rose H, Cui HL, Grant A, Tchoua U, Dart AM, Bukrinsky M, Sviridov D. Antiretroviral compounds and cholesterol efflus from maccophages. Athersclerosis. 2009;206:439-443.
  32. Patel S, Drew BG, Nakhla S, Duffy SJ, Murphy AJ, Barter PJ, Rye K-A, Chin-Dusting J, Hoang A, Sviridov D, Celemmajer DS, Kingwell BA. Reconstituted HDL increases plasma HDL anti-inflammatory properties and cholesterol efflux in patients with type 2 diabetes. J Am Coll Cardiol, 53(11):962-71, 2009.
  33. Pfluger H, Murugasu A, Taylor AJ. An unexpected pericardial tumour. Internal Medicine Journal 2009;39(5):339-40.
  34. Phrommintikul A, Abdel-Aty H, Schulz-Menger J, Friedrich MG, Taylor AJ. Acute oedema in the evaluation of microvascular reperfusion and myocardial salvage in reperfused myocardial infarction with cardiac magnetic resonance imaging. The European Journal of Radiology 2009:Apr 16. [Epub ahead of print].
  35. Pretorius L, Du XJ, Woodcock EA, Kiriazis H, Lin RCY, Marasco S, Medcalf RL, Ming Z, Head GA, Tan J, Cemerlang N, Sadoshima J, Shioi T, Izumo S, Dart AM, Jennings GL, McMullen JR. Reduced phosphoinositide 3-kinase(p110α) increases the susceptibility to atrial fibrillation. The American Journal of Pathology. 2009;175(3):998-1009.
  36. Ritchie RH, Rosenkranz A, Kaye DM. B-Type Natriuretic Peptide: Endogenous Regulator of Myocardial Structure, Biomarker and Therapeutic Target. Curr Mol Med 2009;9:814-25.
  37. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Eng J Med 2009;361(9):932-4.
  38. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension 2009;54(6):1195-201.
  39. Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, Esler MD, Lambert GW. Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009;20(5):933-9.
  40. Schofer, J., Siminiak, T., Haude, M., Herrman, J.P., Vainer, J., Wu, J.C., Levy, W. C., Mauri, L., Feldman, T., Kwong, R.Y., Kaye, D.M., Duffy, S.J., Tubler, T., Degen, H., Brandt, M.C., Van Bibber, R., Goldberg, S., Reuter, D.G., Hoppe, U.C. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation, 2009; 120: 326-33.
  41. Schwartz RS, Burke A, Farb A, Kaye D, Lesser JR, Henry TD, Virmani R. Microemboli and Microvascular Obstruction in Acute Coronary Thrombosis and Sudden Coronary Death. J Am Coll Cardiol 2009;54:2167-73.
  42. Sourris KC, Lyons JG, deCourten MP, Dougherty SL, Henstridge DC, Cooper ME, Dart AM, Kingwell BA, Forbes JM, de Courten B. c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-kappaBactivity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals. Diabetes. 2009;58:1259-65.
  43. Straznicky N, Lambert GW, Masuo K, Dawood T, Eikelis N, Nestel PJ, McGrane MT, Mariani JA, Socratous F, Chopra R, Esler MD, Schlaich MP, Lambert EA. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am J Clin Nutr 2009;89:1-10.
  44. Straznicky N, Lambert GW, McGrane MT, Masuo K, Dawood T, Nestel PJ. Eikelis N, Schlaich MP, Esler MD, Socratus F, Chopra R, Lambert EA. Weight loss reverses blunted sympathetic responsiveness to glucose ingestion in obese metabolic syndrome subjects. Diabetes 2009;58:1126-1132.
  45. Straznicky NE, Lambert GW, Masuo K, Dawood T, Eikelis N, Nestel PJ, McGrane MT, Mariani JA, Socratous F, Chopra R, Esler MD, Schlaich MP, Lambert EA. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am J Clin Nutr 2009;89(1):27-36.
  46. Straznicky NE, Lambert GW, McGrane MT, Masuo K, Dawood T, Nestel PJ, Eikelis N, Schlaich MP, Esler MD, Socratous F, Chopra R, Lambert EA. Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese metabolic syndrome subjects. Diabetes 2009;58(5):1126-32.
  47. White AJ, Duffy SJ, Walton AS, Mukherjee S, Shaw JA, Jennings GL, Dart AM, Kingwell BA. Compliance mismatch between stenotic and distal reference segment is associated with coronary artery disease instability. Athersclerosis. 2009;206:179-185.
  48. Woodcock EA, Grubb DR, Filtz TM, Marasco S, Luo J, McLeod-Dryden TJ, Kaye DM, Sadoshima J, Du XJ, Wong C, McMullen JR, Dart AM. Selective activation of the "b" splice variant of phospholipase Cβ1 in chronically dilated human and mouse atria. J Mol Cell Cardiol. 2009;47:676-683.
  49. Yan, B.P., Clark, D.J., Buxton, B., Ajani, A.E., Smith, J.A., Duffy, S.J., Shardey, G.C., Skillington, P.D., Farouque, O., Yii, M., Yap, C.H., Andrianopoulos, N., Brennan, A., Dinh, D., Reid, C.M. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries. Heart, Lung & Circ, 2009; 18: 184-90.

Book/Chapters

  1. Dart AM. To what extent has monitoring of heart rate reduction become part of your daily practice? Medicographia. 2009;31(4):397.

I am a PATIENT

i-am-a-patient

Consultation in the Heart Centre is only by referral from a Medical Practitioner.

I am a HEALTH PROFESSIONAL

i-am-a-health-professional

Please follow the link to find further information

Your STORIES

our-stories-home

‘This just doesn’t happen to people like me.’  aged 50...

Support US

the-alfred-foundation

Donate or Volunteer for research study. See how you can help.

Copyright © Alferd Health Victoria 2013 | Login